IRIS Accounts Production v24.3.2.46 06999299 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069992992023-12-31069992992024-12-31069992992024-01-012024-12-31069992992022-12-31069992992023-01-012023-12-31069992992023-12-3106999299ns15:EnglandWales2024-01-012024-12-3106999299ns14:PoundSterling2024-01-012024-12-3106999299ns10:Director12024-01-012024-12-3106999299ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3106999299ns10:SmallEntities2024-01-012024-12-3106999299ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3106999299ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3106999299ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3106999299ns10:FullAccounts2024-01-012024-12-3106999299ns10:OrdinaryShareClass12024-01-012024-12-3106999299ns10:Director22024-01-012024-12-3106999299ns10:RegisteredOffice2024-01-012024-12-3106999299ns5:CurrentFinancialInstruments2024-12-3106999299ns5:CurrentFinancialInstruments2023-12-3106999299ns5:Non-currentFinancialInstruments2024-12-3106999299ns5:Non-currentFinancialInstruments2023-12-3106999299ns5:ShareCapital2024-12-3106999299ns5:ShareCapital2023-12-3106999299ns5:SharePremium2024-12-3106999299ns5:SharePremium2023-12-3106999299ns5:RetainedEarningsAccumulatedLosses2024-12-3106999299ns5:RetainedEarningsAccumulatedLosses2023-12-3106999299ns5:PlantMachinery2024-01-012024-12-3106999299ns5:FurnitureFittings2024-01-012024-12-3106999299ns5:PlantMachinery2023-12-3106999299ns5:FurnitureFittings2023-12-3106999299ns5:PlantMachinery2024-12-3106999299ns5:FurnitureFittings2024-12-3106999299ns5:PlantMachinery2023-12-3106999299ns5:FurnitureFittings2023-12-3106999299ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106999299ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3106999299ns5:Non-currentFinancialInstruments2024-01-012024-12-3106999299ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 06999299 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


INNOVATIVE DESIGN ORTHOPAEDICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: G A Sonnino
S D Smith





REGISTERED OFFICE: 6 Brewery Court
High Street
Theale
Reading
Berkshire
RG7 5AJ





REGISTERED NUMBER: 06999299 (England and Wales)





ACCOUNTANTS: Ad Valorem Accountancy Services Limited
Chartered Certified Accountants
2 Manor Farm Court
Old Wolverton Road
Old Wolverton
Buckinghamshire
MK12 5NN

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 23,078 35,218

CURRENT ASSETS
Stocks 5 947,041 786,565
Debtors 6 182,911 247,325
Cash at bank 24,258 13,619
1,154,210 1,047,509
CREDITORS
Amounts falling due within one year 7 312,006 346,288
NET CURRENT ASSETS 842,204 701,221
TOTAL ASSETS LESS CURRENT
LIABILITIES

865,282

736,439

CREDITORS
Amounts falling due after more than one
year

8

463,509

488,211
NET ASSETS 401,773 248,228

CAPITAL AND RESERVES
Called up share capital 10 114 114
Share premium 389,531 389,531
Retained earnings 12,128 (141,417 )
SHAREHOLDERS' FUNDS 401,773 248,228

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2025 and were signed on its behalf by:





S D Smith - Director


INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Innovative Design Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised as the consideration received or receivable from the manufacture and supply of medical and dental instruments and supplies.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 10% on cost
Fixtures, fittings & equipment - 25% on cost

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 4 ) .

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. TANGIBLE FIXED ASSETS
Fixtures,
Plant and fittings &
machinery equipment Totals
£ £ £
COST
At 1 January 2024 210,200 10,010 220,210
Additions - 377 377
At 31 December 2024 210,200 10,387 220,587
DEPRECIATION
At 1 January 2024 177,079 7,913 184,992
Charge for year 11,902 615 12,517
At 31 December 2024 188,981 8,528 197,509
NET BOOK VALUE
At 31 December 2024 21,219 1,859 23,078
At 31 December 2023 33,121 2,097 35,218

5. STOCKS
2024 2023
£ £
Finished goods 947,041 786,565

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 164,263 229,343
Other debtors 18,648 17,982
182,911 247,325

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Bank loans and overdrafts 40,302 37,135
Trade creditors 237,699 269,311
Taxation and social security 18,045 29,324
Other creditors 15,960 10,518
312,006 346,288

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 06999299)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£ £
Bank loans 12,391 40,093
Other creditors 451,118 448,118
463,509 488,211

Of the creditors due within and after more than one year the bank loans are secured.

9. OTHER LOANS

Included in creditors due after more than 1 year are unsecured shareholder loans of £451,118 (2023: £448,118). These loans have been reclassified as long term loans, having been previously presented as current liabilities.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
11,426 Ordinary 0.01 114 114